BNP Paribas Asset Management
TYRA icon

BNP Paribas Asset Management’s Tyra Biosciences TYRA Stock Holding History

BNP Paribas Asset Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.94M Sell
123,420
-5,440
-4% -$180K ﹤0.01% 959
2026
Q1 		$4.94M Sell
128,860
-919
-0.7% -$29.8K 0.01% 860
2025
Q4 		$3.41M Buy
+129,779
New +$2.38M ﹤0.01% 932

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

BNP Paribas Asset Management's TYRA Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Tyra Biosciences (TYRA) stake by 4.2% in Q2 2026, selling an estimated $180K and leaving 123,420 shares worth $3.94M. The position accounts for ﹤0.01% of the portfolio, ranked #959.

BNP Paribas Asset Management first reported a position in TYRA in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.94M in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • BNP Paribas Asset Management held 123,420 shares of Tyra Biosciences worth $3.94M as of Q2 2026.
  • BNP Paribas Asset Management sold 5,440 Tyra Biosciences shares in Q2 2026, an estimated $180K.
  • Tyra Biosciences made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #959 holding.
  • BNP Paribas Asset Management first reported a position in Tyra Biosciences in Q4 2025 and has held it in 3 quarters since.
  • BNP Paribas Asset Management's Tyra Biosciences position peaked at $4.94M in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.